A study (47) in Poland containing 2012 ovarian cancer patients showed that the average age of the ovarian cancer group with CHEK2 was 38 years, while the average age of the CHEK2-negative ovarian cancer group was 49 years. This evidence concerns the gene CHEK2 and ovarian carcinoma.